Keystone Resort Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

New Frontiers in Neuroinflammation: What Happens When CNS and Periphery Meet? (Z4)

joint with the meeting on Advances in Neurodegenerative Disease Research and Therapy (Z3)

Scientific Organizers: Marco Prinz, Jonathan Kipnis and Irene Knuesel


June 17—21, 2018

Keystone Resort, Keystone, Colorado, USA


Sponsored by Biogen, BioLegend, Inc., Genentech, Inc., Merck & Co., Inc., Nestlé Institute of Health Sciences, Roche and Takeda Pharmaceutical Company Limited


Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested.
BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.

DEADLINES:
*All deadlines end at 11:59 PM US Mountain Standard Time
Scholarship Deadline: Feb 15, 2018 [details]
Discounted Abstract Deadline: Feb 15, 2018 [details]
Abstract Deadline: Mar 15, 2018 [details]
Discounted Registration Deadline: Apr 18, 2018 [details]

Click here to view Cancellation Policy

Register Yourself Deadlines and Fees

Rates and Deadlines listed below are for the 2018-Z4 "New Frontiers in Neuroinflammation: What Happens When CNS and Periphery Meet?" conference only.

*All deadlines end at 11:59 PM US Mountain Standard Time

Deadline Date Cost
Discounted Abstract Deadline
More details
Before and On February 15, 2018 100.00 USD*
- 50.00 USD discount
Abstract Deadline
More details
After February 15, 2018 until May 16, 2018 100.00 USD*
* 50.00 USD of Abstract fee deducted from your registration fee when you register for this meeting
Scholarship
More details
February 15, 2018 n/a
Discounted NON-STUDENT Registration
More details
Before and On April 18, 2018 820.00 USD
(includes 200.00 discount)
Regular NON-STUDENT Registration
More details
After April 18, 2018 1020.00 USD
Discounted STUDENT Registration
More details
Before and On April 18, 2018 595.00 USD
(includes 200.00 discount)
Regular STUDENT Registration
More details
After April 18, 2018 795.00 USD

* Changes in payment type that result in a refund are subject to a processing fee.
* Currency exchange gains/losses are the responsibility of the registrant and the Keystone Symposia will accept no liability for money loss through bank charges, transfers or currency fluctuations.




Discounted Abstract Deadline: February 15, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time

Abstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register

Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract early allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • accept your abstract online
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
(The Abstract Deadline: is March 15, 2018)

Global Health Travel Award Deadline:

*All deadlines end at 11:59 PM US Mountain Standard Time


Global Health Travel Award Details: You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline and complete the other required steps (verify your contact information and submit a recommendation letter) to be considered for a travel award.


Click here to learn more about Global Health Travel Awards.

Scholarship Deadline: February 15, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Scholarship Details: You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.

Click here to learn more about Scholarships.

Abstract Deadline: March 15, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register

Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract by the Abstract Deadline allows us to:

  • submit your abstract to organizers to be considered for a short talk
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.

(Discounted Abstract Deadline: is February 15, 2018)

Discounted Registration Deadline: April 18, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Registration Fee: 820.00 USD* (includes 200.00 USD discount)
Student Registration Fee: 595.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

After the Discounted Registration Deadline:


Registration Fee: 1020.00 USD*
Student Registration Fee: 795.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

Registration spaces are limited and may fill prior to discounted registration deadline.

Please be advised that a few meeting participants have received calls and emails from a number of different housing services - "Exhibitors Housing Services", "Global Housing", etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling and seek to take your lodging reservation and obtain your credit card number. We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report to Keystone Symposia any calls or correspondence you might have received and book only through the lodging link on our website, an established travel agency, or directly with the hotel.
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Sunday, June 17 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, June 21 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Friday, June 22 in order to fully experience the meeting.

SUNDAY, JUNE 17

16:00—20:00
Arrival and Registration

Longs Peak Foyer
18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.

Longs Peak Foyer

MONDAY, JUNE 18

07:30—08:30
Breakfast

Colorado Rockies Ballroom
08:30—09:30
Welcome and Keynote Address
Registered attendees can view abstracts starting on 05/17/2018

Grays/Longs Peak
* Marco Prinz, University of Freiburg, Germany

Dorian B. McGavern, NINDS, National Institutes of Health, USA
CNS Myeloid Cell Dynamics Under Steady State and Inflammatory Conditions

08:30—09:30
Welcome and Keynote Address
Registered attendees can view abstracts starting on 05/17/2018

Quandary Peak
* Li Gan, University of California, San Francisco, USA

Huda Y. Zoghbi, HHMI/Baylor College of Medicine, USA
Insights From Rare Disorders Shed Light on Common Neurodegenerative Diseases

09:30—12:00
Immune Privilege, Blood-Brain Barrier and Microglia I
Registered attendees can view abstracts starting on 05/17/2018

Grays/Longs Peak
* Knut Biber, AbbVie Deutschland GmbH & Co. KG, Germany

Josef Priller, Charité – Universitätsmedizin Berlin, Germany
From Bone Marrow to Brain: How Myeloid Cells Can Enter the CNS

Coffee Break

Jonathan Kipnis, University of Virginia, USA
Lymphatics in the CNS and Their Role in Neurological Diseases

Richard Daneman, University of California, San Diego, USA
Regulation of the Blood-Brain Barrier in Health and Disease

Karen De Vlaminck, Vrije Universiteit Brussel, Belgium
Short Talk: The Fate and Dynamics of Microglia, Border Macrophages and Infiltrating Monocytes during the Onset and Resolution of Infectious Neuroinflammation

Cayce Dorrier, University of California, San Diego, USA
Short Talk: The Role of the Fibrotic Scar in Repair following Neuroinflammation

09:30—12:00
Genetics to Epigenetics in Neurodegenerative Diseases
Registered attendees can view abstracts starting on 05/17/2018

Quandary Peak
* Aaron D. Gitler, Stanford University School of Medicine, USA

John Hardy, University College London, Institute of Neurology, UK
Genomics and Pathways to Neurodegeneration

Coffee Break

Catherine Marquer, Columbia University, USA
Short Talk: Excess Synaptojanin 1 Drives Age-Dependent Cognitive Deficits, a Unifying Mechanism for Individuals at High Risk of Alzheimer's Disease

Alison Goate, Mount Sinai School of Medicine, USA
Genetic Studies Implicate Microglial Function in Alzheimer's Disease Risk

Li-Huei Tsai, Massachusetts Institute of Technology, USA
Transcriptomic Analysis at Single Cell Resolution in Neurodegeneration

John D. Fryer, Mayo Clinic, USA
Short Talk: Translational Profiling of Microglia Reveals a Shared apoE Pathway Common to Aging, Amyloid and Tau Pathology

12:00—17:00
On Own for Lunch

12:00—13:00
Poster Setup

Colorado Rockies Ballroom
13:00—22:00
Poster Viewing

Colorado Rockies Ballroom
16:30—17:00
Coffee Available

Longs Peak Foyer
17:00—19:00
Immune Privilege, Blood-Brain Barrier and Microglia II
Registered attendees can view abstracts starting on 05/17/2018

Grays/Longs Peak
* Bart J.L. Eggen, University Medical Center Groningen, Netherlands

Marco Prinz, University of Freiburg, Germany
Myeloid Cell Activation and Kinetics in the Brain

Doron Merkler, University of Geneva, Switzerland
Interaction between Neurons, Phagocytes and T Cells in Neuroinflammation

Michal Schwartz, Weizmann Institute of Science, Israel
Fighting Alzheimer's Disease by Unleashing the Innate and Adaptive Immune Cells

Zhen Xu, Shenzhen University, China
Short Talk: Repopulated Microglia Are Solely Derived from the Proliferation of Residual Microglia after Acute Depletion

17:00—19:00
Aging in Health and Disease
Registered attendees can view abstracts starting on 05/17/2018

Quandary Peak
* Morgan H. Sheng, Genentech, Inc., USA

Andrew G. Dillin, University of California, Berkeley, USA
Aging in Protein, Homeostasis and Stress

Ana Maria Cuervo, Albert Einstein College of Medicine, USA
Contribution of Aging of Selective Autophagy to Neurodegeneration

Tony Wyss-Coray, Stanford University School of Medicine, USA
Dissecting the Role of Cerebrovascular Dysfunction in Brain Aging

Edward Giniger, NINDS, National Institutes of Health, USA
Short Talk: Separating the Roles of Autophagy, Immunity and Aging in Neurodegeneration

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Colorado Rockies Ballroom
19:30—22:00
Poster Session 1

Colorado Rockies Ballroom

TUESDAY, JUNE 19

07:30—08:30
Breakfast

Colorado Rockies Ballroom
08:30—11:45
Cross-Talk of Microglia with Other CNS Cells
Registered attendees can view abstracts starting on 05/17/2018

Grays/Longs Peak
* Katrin Kierdorf, Uniklinik Freiburg, Germany

Mikael Simons, Technische Universität München, Germany
Cholesterol Metabolisms as Key Regulator of Phagocyte Function during Remyelination

Francisco J. Quintana, Harvard Medical School, USA
Astrocytes and Microglia

Coffee Break

Anna Victoria Molofsky, University of California, San Francisco, USA
Astrocyte-Microglial Communication in Developmental Synapse Remodeling

Burkhard Becher, University of Zurich, Switzerland
T Cell Entry into the CNS: How Myelin Is Presented

Courtney Malo, Mayo Clinic, USA
Short Talk: MHC Class I Expression by Microglia Is Required for Generating a Complete Antigen-Specific CD8 T Cell Response in the CNS

Phi T. Nguyen, University of California, San Francisco, USA
Short Talk: The IL-33-IL1RL1 Signaling Axis Coordinates Remodeling and Integration of Adult-Born Neurons in the Hippocampus

08:30—12:00
Innate Immunity
Registered attendees can view abstracts starting on 05/17/2018

Quandary Peak
* David M. Holtzman, Washington University, USA

Adriano M. Aguzzi, University Hospital of Zürich, Switzerland
Protein Aggregation and Pathways of Toxicity

Christian Haass, Ludwig-Maximilians University Munich, Germany
Loss of TREM2 Function Increases Amyloid Seeding but Reduces Plaque-Associated ApoE

Matthew A. Cooper, University of Queensland, Australia
Short Talk: Pharmacological Inhibition of the NLRP3 Inflammasome Prevents Synuclein Pathology and Dopaminergic Degeneration in Parkinson's Disease

Coffee Break

Christopher K. Glass, University of California, San Diego, USA
Genomic Approaches to Dissect Innate Immunity in Neurodegeneration

Li Gan, University of California, San Francisco, USA
Microglia in Tau Proteostasis and Toxicity

Andrew B. West, University of Alabama at Birmingham, USA
Short Talk: LRRK2 Mediates the Recruitment of Monocyte-Derived Macrophages to the Brain in Neurodegeneration

11:45—17:00
On Own for Lunch

11:45—13:00
Poster Setup

Colorado Rockies Ballroom
13:00—22:00
Poster Viewing

Colorado Rockies Ballroom
16:30—17:00
Coffee Available

Longs Peak Foyer
17:00—19:00
Myeloid Cells and Neuroinflammation
Registered attendees can view abstracts starting on 05/17/2018

Grays/Longs Peak
* Erik H.W.G.M. Boddeke, University of Groningen, Netherlands

Masaaki Murakami, Hokkaido University, Japan
Neural Stimulations Modulate the Formation of Immune Cell Gateways into the CNS

Akihiko Yoshimura, Keio University, Japan
Regulation of Inflammation after Stroke by Macrophages and Regulatory T Cells

Robyn S. Klein, Washington University School of Medicine, USA
Trm-Derived IFNg Causes Microglial-Mediated Spatial Learning Defects during Recovery from Differentially Neurotropic Flaviviruses

Kevin G. Burfeind, Oregon Health & Science University, USA
Short Talk: Infiltrating Myeloid Cells in the Central Nervous System Mediate Cancer Cachexia

17:00—19:00
Neuronal and Network Dysfunction in Neurodegeneration
Registered attendees can view abstracts starting on 05/17/2018

Quandary Peak
* Li-Huei Tsai, Massachusetts Institute of Technology, USA

Huaxi Xu, Sanford Burnham Prebys Medical Discovery Institute, USA
A Novel Mechanism for Memory/Synaptic Dysfunction in Tauopathy

Zayd M. Khaliq, NINDS, National Institutes of Health, USA
Dendritic Ca2+ Signaling in Substantia Nigra Dopamine Neuron Subpopulations

Morgan H. Sheng, Genentech, Inc., USA
Mechanisms of Synapse Loss Revealed by Proteomic Analysis of Post-Synaptic Density in Tauopathy Mouse Model

Keran Ma, University of California, San Francisco, USA
Short Talk: Nav1.1-Overexpressing Interneuron Transplants Restore Brain Rhythms and Cognition in a Mouse Model of Alzheimer's Disease

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Colorado Rockies Ballroom
19:30—22:00
Poster Session 2

Colorado Rockies Ballroom

WEDNESDAY, JUNE 20

07:30—08:30
Breakfast

Colorado Rockies Ballroom
08:30—11:45
Imaging of the Healthy and Diseased CNS
Registered attendees can view abstracts starting on 05/17/2018

Grays/Longs Peak
* Sophia Bardehle, Merck, USA

Wenbiao Gan, Skirball Institute Program of Molecular Neurobiology, USA
The Role of Microglia in Learning-Dependent Synaptic Plasticity

Martin Kerschensteiner, Ludwig Maximilians University Munich, Germany
In vivo Analysis of Phagocyte Phenotypes and Effector Function

Coffee Break

Melanie Meyer-Luehmann, University of Freiburg, Germany
Microglia Contribution to the Propagation of Abeta Pathology

Francesca Peri, European Molecular Biology Laboratory, Germany
Microglia and Neuronal Interactions

Anna Mechling, Roche Innovation Center Basel, Hoffmann-La Roche Ltd., Switzerland
Short Talk: Pivotal Role of Microglial TREM2 in Remyelination as Revealed by Multiparametric Magnetic Resonance Imaging in the Cuprizone Mouse Model

Vijayasree V. Giridharan, University of Texas Health Science Center, USA
Short Talk: Imaging of Microglial Activation in Experimental Bacterial Meningitis using PET/CT

08:30—11:45
Protein Trafficking and Degradation
Registered attendees can view abstracts starting on 05/17/2018

Quandary Peak
* Tony Wyss-Coray, Stanford University School of Medicine, USA

Baris Bingol, Genentech, Inc., USA
Lysosomal Degradation in Parkinson’s Disease

Guojun Bu, Mayo Clinic, USA
Central and Peripheral ApoE4 in Cognition and Dementia

Michael E. Ward, NINDS, National Institutes of Health, USA
Short Talk: Progranulin Mediates Endolysosomal Recruitment of the RNP-Associated Protein ANXA11

Coffee Break

David M. Holtzman, Washington University, USA
Effects of ApoE in Tau-Mediated Neurodegeneration

Jaehong Suh, Harvard Medical School, USA
Short Talk: Role of Ataxin-1 in BACE1 Expression and Axonal Targeting in the Cerebrum

R. Jeremy Nichols, Parkinson's Institute, USA
Short Talk: SQSTM1/p62 Is a Novel Substrate of the Parkinson's Disease Kinase LRRK2 that Activates its Kinase Domain and Enhances Neuronal Toxicity

Naruhiko Sahara, National Institute of Radiological Sciences, Japan
Short Talk: Neuroinflammatory Process during Pathogenesis of Tauopathy in rTg4510 Mice

11:45—17:00
On Own for Lunch

11:45—13:00
Poster Setup

Colorado Rockies Ballroom
13:00—22:00
Poster Viewing

Colorado Rockies Ballroom
16:30—17:00
Coffee Available

Longs Peak Foyer
17:00—19:00
Myeloid Cells as Targets of Drug Discovery and Biomarkers
Registered attendees can view abstracts starting on 05/17/2018

Grays/Longs Peak
* Andrea Crotti, Biogen, USA

Irene Knuesel, Roche Innovation Center Basel, Switzerland
Therapeutic Effects of Anti-Amyloid-Beta Immunotherapy on Myeloid Cell Transcriptome

Melanie Greter, University of Zurich, Switzerland
Microglia Gene Modifications

David R. Owen, Imperial College London, UK
Imaging Microglia in Humans

Paul R. Ormel, University Medical Center Utrecht, Netherlands
Short Talk: Comparison of Three Human Microglia Models to Study Schizophrenia

17:00—19:00
Disease Modeling
Registered attendees can view abstracts starting on 05/17/2018

Quandary Peak
* Leonard Petrucelli, Mayo Clinic Jacksonville, USA

Leslie M. Thompson, University of California, Irvine, USA
A Systems Biology Approach to Understanding ALS Pathogenesis in iPSC-Derived Motor Neurons

Albert R. La Spada, Duke University, USA
Deconstructing Polyglutamine Neurodegeneration: From Pathways of Neuron Demise to Therapeutic Intervention

Yadong Huang, Gladstone Institutes/UCSF, USA
Modeling and Drug Screening of AD Using Patients-Derived iPSCs

Michael Lee, University of Minnesota, USA
Short Talk: Dissociation of Amyloid Dependent Cognitive Deficits and Neurodegeneration

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Colorado Rockies Ballroom
19:30—22:00
Poster Session 3

Colorado Rockies Ballroom

THURSDAY, JUNE 21

07:30—08:30
Breakfast

Colorado Rockies Ballroom
08:30—11:45
Myeloid Gene Regulation
Registered attendees can view abstracts starting on 05/17/2018

Grays/Longs Peak
* Inge R. Holtman, University of California, San Diego, USA

Oleg Butovsky, Harvard Medical School, USA
Dual Faces of Dr. Jekyll Microglia: Degenerating Neurons Cannot "Hyde"

Ido Amit, Weizmann Institute, Israel
The Power of ONE: Immunology in the Age of Single Cell Genomics

Coffee Break

Marco Colonna, Washington University School of Medicine, USA
TREM2, Microglia and Neurodegeneration

Bahareh Ajami, Stanford University School of Medicine, USA
Single-Cell Mass Cytometry Reveals Molecular Signatures of Inflammation in Contrasting Models of Neuroinflammation versus Neurodegeneration

Kendra Lechtenberg, Stanford University, USA
Profiling Microglia-Specific Transcriptional Changes after Ischemic Stroke

Carole Lara Veiga Sousa, Luxembourg Institute of Health, Luxembourg
Short Talk: Molecular Profiling of Microglia in Steady State and Under Inflammatory Conditions at Single-Cell Level

08:30—11:45
RNA Metabolisms and New Mechanisms of Toxicity
Registered attendees can view abstracts starting on 05/17/2018

Quandary Peak
* Yadong Huang, Gladstone Institutes/UCSF, USA

J. Paul Taylor, St. Jude Children's Research Hospital, USA
Disturbance of Phase Transitions in Neurological Disease

Aaron D. Gitler, Stanford University School of Medicine, USA
Expanding Mechanisms of C9orf72 Mutations in ALS and FTD

Zevik Melamed, University of California, San Diego, USA
Short Talk: RNA Processing Alteration and the Link to Neurodegeneration in ALS/FTD

Coffee Break

Leonard Petrucelli, Mayo Clinic Jacksonville, USA
C9 Biology and Biomarkers

Bess Frost, Barshop Institute for Longevity and Aging Studies, USA
Jump Around, Jump Around: Transposable Element Activation in Tauopathy

Xin Qi, Case Western Reserve University, USA
Short Talk: ATAD3A Oligomerization Causes Neurodegeneration by Coupling Mitochondrial Fragmentation and Bioenergetics Defects

11:30—17:00
On Own for Lunch

14:30—16:30
Workshop: Systems Approach and Functional Genomics

* Martin Kampmann, University of California, San Francisco, USA
Elucidating Cellular Mechanisms and Therapeutic Strategies for Neurodegenerative Diseases with CRISPRi and CRISPRa

Taisuke Kato, Niigata University, Japan
Phenotypic Suppression of DRPLA Model Mice using CRISPR / Cas9 System

Jiyoen Kim†, Baylor College of Medicine, USA
Identifying Therapeutic Targets for Alzheimer's Disease: A Cross-Species Genetic Screen for Molecules that Lower Tau Levels

Alan E. Renton, Icahn School of Medicine at Mount Sinai, USA
Short Talk: Alzheimer's Disease Sequencing Project: Age Extremes x APOE Genotype Sampling for Genetic Discovery

Tara E. Tracy, University of California, San Francisco, USA
Spatiotemporal Mapping of the Tau Interactome in Human iPSC-Derived Neurons

Tal Nuriel, Columbia University Medical Center, USA
Utilizing Systems Biology Approaches to Elucidate the Effects of APOE4 Expression in an AD-Vulnerable Brain Region

Rakshita A. Charan, University of Pennsylvania, USA
Identification and Characterization of Frontotemporal Dementia Risk Factor TMEM106B Interacting Proteins

16:30—17:00
Coffee Available

Longs Peak Foyer
17:00—18:45
Microglia and CNS Diseases
Registered attendees can view abstracts starting on 05/17/2018

Grays/Longs Peak
* Annett Halle, German Center for Neurodegenerative Diseases, Germany

Shane Antony Liddelow, New York University Langone Medical Center, USA
What Do Reactive Astrocytes Do?

Florent Ginhoux, Singapore Immunology Network, Singapore
Microglia Heterogeneity

Philip L. De Jager, Columbia University Medical Center, USA
The Genetic and Population Architecture of Aged Human Microglia: Role in Accelerating Tau Pathology and Cognitive Decline

17:00—18:45
Biomarker and Therapeutics
Registered attendees can view abstracts starting on 05/17/2018

Quandary Peak
* Li Gan, University of California, San Francisco, USA

William J. Jagust, University of California, Berkeley, USA
Imaging Tau and Beta-Amyloid in the Human Brain

C. Frank Bennett, Ionis Pharmaceuticals, Inc., USA
Antisense Oligonucleotide-Based Therapies for Neurological Diseases

Rita Balice-Gordon, Sanofi, Inc., USA
Translational Challenges in Neuroscience Drug Development

Tracy Cole, Ionis Pharmaceuticals, Inc., USA
Short Talk: Human SNCA Antisense Oligonucleotides Reduce CNS and CSF Alpha-Synuclein Levels in a Non-Human Primate Model, Supporting their Use for Treatment of Synucleinopathies

18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 05/17/2018

Grays/Longs Peak
18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 05/17/2018

Quandary Peak
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Colorado Rockies Ballroom
20:00—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Colorado Rockies Ballroom

FRIDAY, JUNE 22

 
Departure


*Session Chair †Invited, not yet responded.



We gratefully acknowledge support for this conference from:


Directors' Fund


These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.

Click here to view all of the donors who support the Directors' Fund.



Keystone Symposia thanks our Sponsors for generously supporting this meeting:

Biogen BioLegend, Inc.
Genentech, Inc. Merck & Co., Inc.
Nestlé Institute of Health Sciences Roche
Takeda Pharmaceutical Company Limited
 

We gratefully acknowledge additional support from these exhibitors at this conference:

The Paul G. Allen Frontiers Group
Please stop by to meet these exhibitors during the conference.


We gratefully acknowledge the generous grant for this conference provided by:


National Institutes of Health

Grant No. 1R13NS106976-01

Funding for this conference was made possible (in part) by 1R13NS106976-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.


We gratefully acknowledge additional support for this conference from:

Abcam plc Bio-Techne

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676